Lloyd Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Lloyd Advisory Services's PFE Position: Q2 2026 in Review
Lloyd Advisory Services increased its Pfizer (PFE) stake by 1,291% in Q2 2026, buying an estimated $227K and bringing the position to 9,335 shares worth $225K. The position accounts for 0.09% of the portfolio, ranked #104.
Lloyd Advisory Services first reported a position in PFE in Q4 2019 and has held it in 20 quarters since. The position peaked at $878K in Q3 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Lloyd Advisory Services held 9,335 shares of Pfizer worth $225K as of Q2 2026.
- Lloyd Advisory Services bought 8,664 Pfizer shares in Q2 2026, an estimated $227K.
- Pfizer made up 0.09% of Lloyd Advisory Services's portfolio in Q2 2026, its #104 holding.
- Lloyd Advisory Services first reported a position in Pfizer in Q4 2019 and has held it in 20 quarters since.
- Lloyd Advisory Services's Pfizer position peaked at $878K in Q3 2023.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.